Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant

被引:5
作者
Chua, HL
Brahmi, Z
机构
[1] Indiana Univ, Sch Med, Dept Immunol Microbiol, Riley Hosp, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med, Riley Hosp, Indianapolis, IN 46202 USA
关键词
D O I
10.1016/S0008-8749(02)00578-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer cytotoxicity is down-regulated by HLA Class I-specific inhibitory receptors classified as killer inhibitory receptors (KIRs) or C-type lectins. The regulation of their inhibitory signaling pathways is not completely understood. The YTINDY NK-like cell line was transfected to express p58.2 KIR (YT/C143 transfectant) or CD94/NKG2A C-type lectin (YT/CD94 transfectant); and YT/C143, but not YT/CD94, cytotoxicity was down-regulated by Class 1. YT/C143 and YT/CD94 expressed equally low p56(Ick) levels, suggesting that p56(Ick) is not absolutely required for p58.2 signaling but may be required for CD94/NKG2A signaling. Lower SHP-1 levels and activity were observed in YT/CD94 compared to YT/C 143. However, increasing SHP-1 to equivalent levels in YT/ C143 did not restore inhibition in YT/CD94. Our results suggest that the combination of low p56(lck) and SHP-1 levels may be responsible for the absent inhibitory signal in YT/CD94. In addition, the possible expression of CD94/NKG2C activating receptor may override inhibitory signals transduced through CD94/NKG2A. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:57 / 70
页数:14
相关论文
共 57 条
[1]   Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation [J].
Binstadt, BA ;
Brumbaugh, KM ;
Dick, CJ ;
Scharenberg, AM ;
Williams, BL ;
Colonna, M ;
Lanier, LL ;
Kinet, JP ;
Abraham, RT ;
Leibson, PJ .
IMMUNITY, 1996, 5 (06) :629-638
[2]  
Blery M, 1997, J BIOL CHEM, V272, P8989
[3]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[4]  
BRAHMI Z, 1985, J IMMUNOL, V135, P4108
[5]   The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 [J].
Braud, V ;
Jones, EY ;
McMichael, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) :1164-1169
[6]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[7]  
Brooks AG, 1999, J IMMUNOL, V162, P305
[8]   NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor [J].
Brooks, AG ;
Posch, PE ;
Scorzelli, CJ ;
Borrego, F ;
Coligan, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :795-800
[9]   Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor [J].
Burshtyn, DN ;
Scharenberg, AM ;
Wagtmann, N ;
Rajagopalan, S ;
Berrada, K ;
Yi, TL ;
Kinet, JP ;
Long, EO .
IMMUNITY, 1996, 4 (01) :77-85
[10]  
Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO